financetom
Business
financetom
/
Business
/
Rambus Insider Sold Shares Worth $487,289, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Rambus Insider Sold Shares Worth $487,289, According to a Recent SEC Filing
Mar 12, 2024 10:27 AM

01:11 PM EDT, 03/12/2024 (MT Newswires) -- Desmond Lynch, Senior Vice President, CFO, on March 11, 2024, sold 7,837 shares in Rambus ( RMBS ) for $487,289. Following the Form 4 filing with the SEC, Lynch has control over a total of 41,958 shares of the company, with 41,958 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/917273/000091727324000038/xslF345X03/wk-form4_1710263273.xml

Price: 62.55, Change: +0.03, Percent Change: +0.05

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Hyundai Motor India set to price shares at top of range to raise $3.3 billion, sources say
Hyundai Motor India set to price shares at top of range to raise $3.3 billion, sources say
Oct 17, 2024
(Reuters) -Hyundai Motor India is set to price its shares at 1,960 rupees to raise $3.3 billion in its initial public offering, according to two sources with direct knowledge of the matter. That price is at the top of the 1,865 rupees to 1,960 rupees range flagged to investors when the deal was launched. Hyundai India is selling 142.2 million...
Carlyle-backed Rigaku raises $863 mln in Tokyo IPO
Carlyle-backed Rigaku raises $863 mln in Tokyo IPO
Oct 17, 2024
TOKYO, Oct 17 (Reuters) - Rigaku Holdings raised 129 billion yen ($863 million) after the Japan X-ray testing tool maker priced its IPO at the top of its range, according to a regulatory filing on Thursday. The company, which is backed by buyout firm Carlyle Group ( CG ), priced the IPO at 1,260 yen per share, at the top...
Merck lowers mid-term healthcare outlook after recent drug failures
Merck lowers mid-term healthcare outlook after recent drug failures
Oct 17, 2024
Oct 17 (Reuters) - German science and technology company Merck ( MRK ) lowered mid-term targets for its Life Sciences and Healthcare businesses, anticipating an update on China's growth prospects and following a string of setbacks in its drug development. The company narrowed expectations for its Life Science business, aiming for a 7-9% range from a previously anticipated 7-10%, it...
Rentokil expects hit to 2025 profit on delay in Terminix deal synergy
Rentokil expects hit to 2025 profit on delay in Terminix deal synergy
Oct 17, 2024
Oct 17 (Reuters) - British pest control company Rentokil Initial ( RTO ) said on Thursday its profit and margins in 2025 will be hurt by a delay of about two to three months in realizing synergies from its acquisition U.S. rival Terminix. (Reporting by Yamini Kalia in Bengaluru; Editing by Subhranshu Sahu) ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved